Rosuvastatin Therapy Guidelines

Introduction to Rosuvastatin Dosing

• The American College of Cardiology recommends moderate-intensity rosuvastatin as 5-10 mg once daily, achieving a 30-50% reduction in LDL-C, for patients with high cardiovascular risk 1, 2

Dosing Framework

• The American College of Cardiology/American Heart Association guidelines establish three intensity categories for statin therapy based on expected LDL-C reduction, with moderate-intensity rosuvastatin defined as 5-10 mg daily 1
• Moderate-intensity rosuvastatin (5-10 mg daily) is expected to reduce LDL-C by 30-50% 1, 2
• High-intensity rosuvastatin (20-40 mg daily) is expected to reduce LDL-C by ≥50% 1, 5

Special Considerations

• For patients with mild to moderate renal impairment (CrCl ≥30 mL/min), standard moderate-intensity dosing (5-10 mg) remains appropriate 4
• For patients with severe renal impairment (CrCl <30 mL/min), initiate at 5 mg once daily and do not exceed 10 mg daily 4
• The maximum dose of 10 mg daily in severe renal impairment represents the upper limit of moderate-intensity therapy 4

Clinical Context for Heart Disease Patients

• For patients with established heart disease and mild-moderate renal impairment (CrCl ≥30 mL/min), high-intensity therapy (20-40 mg) is recommended unless contraindicated 4
• For patients with established heart disease and severe renal impairment (CrCl <30 mL/min), the maximum dose is 10 mg daily (moderate-intensity) 4

Important Caveat for Dialysis Patients

• The American College of Cardiology recommends not initiating rosuvastatin in patients already on hemodialysis, though continuation is reasonable if already established on therapy 4, 3

Practical Implementation

• When prescribing moderate-intensity rosuvastatin, assess LDL-C as early as 4 weeks after initiation and adjust dosage accordingly 4
• Monitor for myopathy risk, especially in patients >65 years, with hypothyroidism, or on interacting medications 4

Asian Patient Considerations

• Asian patients require a lower starting dose of 5 mg daily regardless of renal function due to 2-fold higher plasma concentrations 4